We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPCB icon
1926
SuperCom
SPCB
$71.6M
$24K ﹤0.01%
30
+11
+58% +$8.16K
SPRO icon
1927
Spero Therapeutics
SPRO
$73M
$24K ﹤0.01%
+2,089
New +$25.6K
TDC icon
1928
Teradata
TDC
$2.55B
$24K ﹤0.01%
617
+495
+406% +$17.7K
UUUU icon
1929
Energy Fuels
UUUU
$3.53B
$24K ﹤0.01%
13,307
-6,930
-34% -$11.4K
VIV icon
1930
Telefônica Brasil
VIV
$19.2B
$24K ﹤0.01%
1,599
-1,418
-47% -$21.8K
WVE icon
1931
Wave Life Sciences
WVE
$1.2B
$24K ﹤0.01%
698
-2,444
-78% -$71.3K
TBRG
1932
DELISTED
TruBridge
TBRG
$24K ﹤0.01%
810
-1,494
-65% -$44.5K
TPC
1933
Tutor Perini Cor
TPC
$5.21B
$24K ﹤0.01%
981
-2,172
-69% -$57.8K
AE
1934
DELISTED
Adams Resources & Energy Inc
AE
$24K ﹤0.01%
+560
New +$24.9K
TRHC
1935
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$24K ﹤0.01%
845
+111
+15% +$3.25K
IDEX
1936
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$24K ﹤0.01%
+42
New +$14.7K
FCRD
1937
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$24K ﹤0.01%
2,656
+2,198
+480% +$20.3K
XLRN
1938
DELISTED
Acceleron Pharma
XLRN
$24K ﹤0.01%
567
+65
+13% +$2.44K
MPVD
1939
DELISTED
Mountain Province Diamonds Inc.
MPVD
$24K ﹤0.01%
6,848
+1,597
+30% +$4.56K
BWP
1940
DELISTED
Boardwalk Pipeline Partners
BWP
$24K ﹤0.01%
+1,831
New +$25.9K
WR
1941
DELISTED
Westar Energy Inc
WR
$24K ﹤0.01%
444
-1,522
-77% -$82.1K
CBUS icon
1942
Cibus
CBUS
$138M
$23K ﹤0.01%
21
+18
+600% +$20.4K
CNOB icon
1943
Center Bancorp
CNOB
$1.78B
$23K ﹤0.01%
901
-2,337
-72% -$61.4K
CPT icon
1944
Camden Property Trust
CPT
$11.3B
$23K ﹤0.01%
247
+240
+3,429% +$22.2K
CSGS
1945
DELISTED
CSG Systems International
CSGS
$23K ﹤0.01%
525
-2,194
-81% -$94.7K
CSL icon
1946
Carlisle Companies
CSL
$15.4B
$23K ﹤0.01%
201
-794
-80% -$86.6K
FET icon
1947
Forum Energy Technologies
FET
$835M
$23K ﹤0.01%
72
-234
-76% -$66.6K
HIW icon
1948
Highwoods Properties
HIW
$3.47B
$23K ﹤0.01%
453
+382
+538% +$19.7K
IBCP icon
1949
Independent Bank Corp
IBCP
$844M
$23K ﹤0.01%
987
-773
-44% -$17.4K
INSG icon
1950
Inseego
INSG
$90.5M
$23K ﹤0.01%
1,452
+1,442
+14,420% +$22.4K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.